Trinity Biotech (TRIB) Share-based Compensation (IS) (2021 - 2024)
Trinity Biotech recorded quarterly Share-based Compensation (IS) of $140000.0 in Q4 2024, up 55900.0% quarter-over-quarter from $250.0 in Q3 2024, and up 113.88% year-over-year from $65458.8 in Q1 2024.
Trinity Biotech's Share-based Compensation (IS) history runs 4 years deep, the most recent figure standing at $140000.0 for Q4 2024.
- In Q4 2024, Share-based Compensation (IS) rose 113.88% year-over-year to $140000.0; the TTM figure through Dec 2024 stood at -$130750.0 (down 111.21% YoY), while the FY2024 annual figure was $1.3 million, down 36.39% from the prior year.
- Share-based Compensation (IS) came in at $140000.0 for Q4 2024 at Trinity Biotech, up from $250.0 in the prior quarter.
- In the past five years, Share-based Compensation (IS) ranged from a high of $1.3 million in Q4 2022 to a low of -$1.0 million in Q4 2023.
- A 4-year average of $162298.2 and a median of $119000.0 in 2022 frame the typical range for Share-based Compensation (IS).
- Across the five-year window, Share-based Compensation (IS) soared 755.84% in 2022 and tumbled 176.56% in 2023, its largest moves.
- Trinity Biotech's Share-based Compensation (IS) stood at $154000.0 in 2021, then jumped by 755.84% to $1.3 million in 2022, then sank by 176.56% to -$1.0 million in 2023, then surged by 113.88% to $140000.0 in 2024.
- According to Business Quant data, Share-based Compensation (IS) over the past three periods registered $140000.0, $250.0, and -$1.0 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 250.00 |
| Sep 30, 2024 | 250.00 |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | 738,000.00 |
| Sep 30, 2023 | 738,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 119,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 122.00 |
| Jun 30, 2022 | 122.00 |
| Dec 31, 2021 | 154,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Jun 30, 2021 | 312.00 |
| Jun 30, 2021 | 312.00 |